Find clinical trials for Diabetes in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Philadelphia, PA, USA:
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
Philadelphia, Pennsylvania, United States and 9 other locations
Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...
Phase 2
Philadelphia, Pennsylvania, United States and 56 other locations
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...
Philadelphia, Pennsylvania, United States and 64 other locations
This study will evaluate the safety, efficacy and durability of SR-02 administered to the omentum of patients of Type 1 diabetes with severe...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 1 other location
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Philadelphia, Pennsylvania, United States and 89 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Philadelphia, Pennsylvania, United States and 175 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Philadelphia, Pennsylvania, United States and 654 other locations
The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 15 other locations
it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...
Phase 1
Philadelphia, Pennsylvania, United States and 10 other locations
Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...
Phase 3
Philadelphia, Pennsylvania, United States of America and 60 other locations
Clinical trials
Research sites
Resources
Legal